Posts

A gene therapy may begin with an elegant idea: deliver a genetic instruction to the right cells and change how they behave. Yet between that idea and a treatment lies an enormous manufacturing challenge. ...

What if scientists could control the activity of cells using nothing more than pulses of light? What sounds like science fiction has become one of the most influential technologies in modern biology. Earlier this ...

For families affected by a rare and ultra-rare genetic disorder, the distance between a promising laboratory result and an accessible treatment can feel impossibly large. Developing a gene therapy requires much more than identifying ...

A representative of CTGCT – the Centre of Excellence for Technologies of Gene and Cell Therapy, Gregor Cuzak, attended the 7th regional Caring for Rare 2026 conference in Belgrade on 3 and 4 September, ...

Every cell in the human body contains essentially the same genetic instructions, yet a heart cell behaves very differently from a nerve or skin cell. For many years, scientists assumed that once a cell ...

Cancer treatment has undergone a remarkable transformation over the past decade. What if, instead of relying solely on drugs to attack tumors, we could reprogram a patient's own immune cells to seek out and ...

CRISPR technologies can rewrite a disease-causing DNA sequence, switch a gene off, correct a single genetic letter or even alter gene activity without changing the underlying DNA. Yet a genome editor can only work ...

What if one of the biggest obstacles in gene therapy could be solved by borrowing a concept from everyday life? Just as Velcro joins two separate pieces together to create a strong and functional ...

On 23 July, a workshop was held at the CTGCT following the installation of a new Infinite 200 PRO luminometer. During the session, our colleagues were introduced to the instrument and received hands-on training ...

How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient? In this interview, Duško Lainšček, researcher at the Institute of Chemistry ...

How can Europe accelerate the journey from scientific discovery to life-changing treatments for patients with rare genetic diseases? This question was at the heart of a recent Bloomberg Adria interview featuring Dr. Mojca Benčina ...

On 12 June 2026, representatives of the National Institute of Chemistry and CTGCT visited Gimnazija Jesenice, where they presented modern biological medicines and the development of gene and cell therapies to third-year students.